Skip to content
Sunday, November 15, 2026
Smart Bonus Insight

The Zimbabwean Government Turns Down ‘One-Sided’ American Healthcare Assistance Deal Due to Data Apprehensions

Medical funding image
The proposed American funding would have supported initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

The nation of Zimbabwe has rejected a substantial US healthcare agreement worth 367 million US dollars (£272m) spanning five years due to Washington's insistence on sensitive biological samples.

This rejection came to light after a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa deemed the deal was "unbalanced".

A government representative has since stated that the US was demanding access to biological samples for research and profit while refused to guarantee the benefits from future medical innovations.

"We will now turn to the challenging and unfortunate process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the United States had donated over $1.9bn in health funding to Zimbabwe over the last two decades.

A medical body in Zimbabwe has urged more talks to find a deal acceptable to both sides so the country's vital HIV programme can be sustained.

Wider Implications

This rejection comes after a similar case in Kenya, where a high court blocked a related health funding agreement after legal challenges were raised about the security of citizens' health data.

Since returning to the presidency recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

The agency had administered aid for the American government, but Trump stated its expenditure was "wasteful" and his government was seeking direct bilateral agreements to enhance openness and responsibility.

As per statements, 16 nations in Africa have to date signed similar agreements, constituting over $18.3bn of fresh investment.

Details of the Declined Agreement

The funds for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this cooperation would have delivered significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on HIV treatment through US-supported initiatives," the Ambassador commented.

However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".

"Zimbabwe was being asked to provide its biological resources and data indefinitely, without any corresponding promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.

"In essence, our nation would supply the raw materials for medical research without any certainty that the final treatments would be accessible to our citizens if a new pandemic emerge."

Sovereignty and International Frameworks

Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining frameworks already established through the global organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.

"This system is designed to ensure that when a country contributes its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to develop them."

These objections regarding the US deal "must not be interpreted as hostility towards the US," he added.

"We are open to further discussions with our American counterparts on how future collaboration could be designed in a manner that honours the independence and interests of each country."

Health Experts Reaction

Medical experts said it acknowledged the government's concerns, but recommended that talks need to persist since a large portion of the country's HIV programmes relied on foreign aid.

"In cases where technical issues exist, such as those relating to data governance or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," the group said.

The situation highlights the continuing challenges between accepting much-needed international aid and protecting national sovereignty in an increasingly interconnected world.

DM
The writer

Daniel Marsh

Clara is a personal finance enthusiast and writer with over a decade of experience helping people manage their money better.

Smart Bonus Insight

Type to search articles.